Interpace Biosciences Acquires RedPath Integrated Pathology
Interpace Biosciences acquired RedPath Integrated Pathology for $12.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Interpace Biosciences
- Acquired Company
- RedPath Integrated Pathology
- Price
- $12.0M
- Acquisition Type
- Acquisition
- Announced
- November 3, 2014
Canonical: https://fsome.com/acquisitions/interpace-biosciences-acquires-redpath-integrated-pathology-8164705 · For the full deal terms, timeline, and press references, please enable JavaScript.